Markku Jalkanen (born 1954) is a

scientist A scientist is a person who conducts Scientific method, scientific research to advance knowledge in an Branches of science, area of the natural sciences. In classical antiquity, there was no real ancient analog of a modern scientist. Instead, ...

biotech Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used b ...

entrepreneur and businessman from

Turku Turku ( ; ; sv, Åbo, ) is a city and former capital on the southwest coast of Finland at the mouth of the Aura River, in the region of Finland Proper (''Varsinais-Suomi'') and the former Turku and Pori Province (''Turun ja Porin lääni''; ...

Finland Finland ( fi, Suomi ; sv, Finland ), officially the Republic of Finland (; ), is a Nordic country in Northern Europe. It shares land borders with Sweden to the northwest, Norway to the north, and Russia to the east, with the Gulf of B ...

. He is the CEO of

Faron Pharmaceuticals Faron Pharmaceuticals is a Finnish drug discovery and development company based in Turku, Finland. The company was founded in 2003 by a group led by Markku Jalkanen, who now acts as the company's Chief Executive Officer. It specialises in the d ...

, a Finnish biopharmaceutical company listed on London's

Alternative Investment Market AIM (formerly the Alternative Investment Market) is a sub-market of the London Stock Exchange that was launched on 19 June 1995 as a replacement to the previous Unlisted Securities Market (USM) that had been in operation since 1980. It allows ...

and Nasdaq's First North Growth Market. Jalkanen was the founding CEO and President of Biotie Therapies, the first publicly traded biotech-company in Finland. He is an advisor for the Finnish life-science fund, Inveni Capital.

Education and career

Jalkanen obtained a master's degree in Medical Biochemistry from the

University of Kuopio The University of Eastern Finland ( fi, Itä-Suomen yliopisto) is a university in Finland founded in 2010 with campuses in Joensuu and Kuopio. History The Finnish Parliament passed the Universities Act on June 16, 2009, which, among other things ...

, a PhD in Medical Biochemistry from the

University of Turku sv, Åbo universitet , latin_name = Universitas Aboensis , image_name = University of Turku.svg , motto = ''Vapaan kansan lahja vapaalle tieteelle'' , established = 1920 , type ...

and completed his post-doctoral training at

Stanford University Stanford University, officially Leland Stanford Junior University, is a private research university in Stanford, California. The campus occupies , among the largest in the United States, and enrolls over 17,000 students. Stanford is consider ...

. He obtained the position of docent in Biochemistry from University of Helsinki and the same qualification in Molecular and Cell Biology from the University of Turku. Jalkanen has received awards for his scientific research and business achievements: The Anders Jahre Medical Prize for Younger Researchers in 1993, The Developer of Turku Award of 1993, The 1994 Academic Publicity Award, Teacher of the Year 1996 of the University of Turku, The Inno-Suomi Award in 1998 for the entrepreneurial industrialization of academic discoveries (BioTie). Jalkanen pioneered Finnish biotech development while being the first Director (Professor) of Turku Biotechnology Center within BioCity community in Turku. He has published over 130 peer-reviewed scientific publications in various highly ranked international journals and has a HIRSCH-index of >45.

References

{{DEFAULTSORT:Jalkanen, Markku 1954 births Living people University of Turku alumni Stanford University alumni Finnish biochemists People from Turku